SANJEEV B PATEL

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology DOVER, DE NPI 1154583243

General Payments — all program years on this page

$3,240.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 160
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $437.63 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $437.6318

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,267.0667
2019 $377.5625
2020 $148.949
2021 $287.5913
2022 $370.2915
2023 $351.2113
2024 $437.6318

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087334439 Novartis Pharmaceuticals Corporation $24.64 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334441 Novartis Pharmaceuticals Corporation $21.00 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334443 Novartis Pharmaceuticals Corporation $17.32 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334445 Novartis Pharmaceuticals Corporation $7.67 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334447 Novartis Pharmaceuticals Corporation $3.66 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334449 Novartis Pharmaceuticals Corporation $22.10 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334455 Novartis Pharmaceuticals Corporation $22.51 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087334463 Novartis Pharmaceuticals Corporation $24.34 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092329754 Boston Scientific Corporation $15.34 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092329756 Boston Scientific Corporation $23.58 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092329758 Boston Scientific Corporation $24.92 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117088368 Medtronic, Inc. $15.48 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124873191 Abbott Laboratories $20.50 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124873193 Abbott Laboratories $17.03 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124873195 Abbott Laboratories $13.27 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124873197 Abbott Laboratories $38.80 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138829494 Edwards Lifesciences Corporation $13.58 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144690163 GE HEALTHCARE $111.89 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.